Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Aug 24, 2007 at 1:21 PM EDT

IPO FILING: Precision Therapeutics

Precision Therapeutics is a life sciences company developing and commercializing tests intended to assist physicians in individualizing cancer therapy in…

Douglas A. McIntyre | Aug 24, 2007 at 10:19 AM EDT

What Options Trading Signals For Arena Pharmaceuticals’ Lorcaserin Safety Review (ARNA)

Business Week noted Arena Pharmaceuticals Inc. (NASDAQ:ARNA) as one of its three "Inside Wall Street" weekly stock picks this morning,…

Douglas A. McIntyre | Aug 22, 2007 at 11:04 AM EDT

IPO FILING: Adnexus Therapeutics, Targeting Avastin (ADNX, BMY)

ADNEXUS THERAPEUTICS, INC. has filed to come public via an IPO with the filed amount to sell up to $86,250,000…

Douglas A. McIntyre | Aug 17, 2007 at 1:39 PM EDT

Earnings Preview: Medtronic August 2007 (MDT)

Medtronic (NYSE:MDT) posts earnings after the close on Tuesday, August 21, and First Call estimates are $0.62 EPS on $3.17…

Douglas A. McIntyre | Aug 17, 2007 at 9:17 AM EDT

IPO FILING: Concentric Medical, A Stroke Treatment Device (CLOT)

A medical device company for the treatment of strokes called Concentric Medical, Inc. has filed to come public via an…

Douglas A. McIntyre | Aug 16, 2007 at 8:18 AM EDT

IPO Filing: Reliant Technologies, Cosmetic Lasers (PMTI, ELOS, CLZR)

Reliant Technologies, Inc. has filed to come public via an IPO with an undetermined ticker and undetermined exchange. For filing…

Douglas A. McIntyre | Aug 15, 2007 at 4:07 PM EDT

Amgen Moves From Biotech to Big Pharma, With More Baggage

Amgen Inc. (NASDAQ:AMGN) did what Wall Street thought it would in its after-the-bell conference call. The biotech giant announced layoffs…

Douglas A. McIntyre | Aug 10, 2007 at 8:05 AM EDT

Wyeth (WYE): More Bad News

Wyeth’s (WYE) shares are off 10% over the last three months, and trade near their 52-week low. The stock is…

Douglas A. McIntyre | Aug 9, 2007 at 1:56 PM EDT

IPO Filing: Peplin (PLIN)

Today was an interesting IPO filing for a company called Peplin, Inc., a subsidiary of Peplin Limited in Australia. There…

Douglas A. McIntyre | Aug 7, 2007 at 3:33 PM EDT

Dendreon Shows Lower Expenses (DNDN)

Dendreon (NASDAQ:DNDN) has posted its results. The actual EPS and revenues don’t matter because of the stage of the company. …

Douglas A. McIntyre | Aug 3, 2007 at 11:44 AM EDT

Looking Beyond Dendreon’s Upcoming Earnings Release (DNDN)

Dendreon Corp. (NASDAQ:DNDN) will release earnings next Tuesday, August 7, after the close. The volatility in shares has dried up…

Douglas A. McIntyre | Jul 18, 2007 at 5:59 AM EDT

Pfizer’s (PFE) Bad Hair Day

Not a good quarter for Pfizer (PFE). Second quarter revenue fell 6% to $11.1 billion. Net income was down 48%…

Douglas A. McIntyre | Jul 16, 2007 at 11:13 AM EDT

Dendreon: A New Form of Shareholder Activism (DNDN)

There was a bit of an unusual message this morning, and that was an advertisement about Dendreon’s (NASDAQ:DNDN) Provenge in…

Douglas A. McIntyre | Jul 11, 2007 at 7:28 AM EDT

Dendreon’s New Hurdle: The SEC (DNDN)

It appears that Dendreon (NASDAQ:DNDN) may be an SEC target now, or at least it is going to get the…

Douglas A. McIntyre | Jul 5, 2007 at 7:55 AM EDT

Dendreon Options Trading: Hope or Hearsay?

Dendreon (DNDN-NASDAQ) is trading up almost another 2% pre-market after Tuesday options activity had shares up $0.47 to close at…

1 … 366 367 368 369 370 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

IPO FILING: Precision Therapeutics

What Options Trading Signals For Arena Pharmaceuticals’ Lorcaserin Safety Review (ARNA)

IPO FILING: Adnexus Therapeutics, Targeting Avastin (ADNX, BMY)

Earnings Preview: Medtronic August 2007 (MDT)

IPO FILING: Concentric Medical, A Stroke Treatment Device (CLOT)

IPO Filing: Reliant Technologies, Cosmetic Lasers (PMTI, ELOS, CLZR)

Amgen Moves From Biotech to Big Pharma, With More Baggage

Wyeth (WYE): More Bad News

IPO Filing: Peplin (PLIN)

Dendreon Shows Lower Expenses (DNDN)

Looking Beyond Dendreon’s Upcoming Earnings Release (DNDN)

Pfizer’s (PFE) Bad Hair Day

Dendreon: A New Form of Shareholder Activism (DNDN)

Dendreon’s New Hurdle: The SEC (DNDN)

Dendreon Options Trading: Hope or Hearsay?

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Health and Healthcare Articles

All Health and Healthcare Articles

IPO FILING: Precision Therapeutics

What Options Trading Signals For Arena Pharmaceuticals’ Lorcaserin Safety Review (ARNA)

IPO FILING: Adnexus Therapeutics, Targeting Avastin (ADNX, BMY)

Earnings Preview: Medtronic August 2007 (MDT)

IPO FILING: Concentric Medical, A Stroke Treatment Device (CLOT)

IPO Filing: Reliant Technologies, Cosmetic Lasers (PMTI, ELOS, CLZR)

Amgen Moves From Biotech to Big Pharma, With More Baggage

Wyeth (WYE): More Bad News

IPO Filing: Peplin (PLIN)

Dendreon Shows Lower Expenses (DNDN)

Looking Beyond Dendreon’s Upcoming Earnings Release (DNDN)

Pfizer’s (PFE) Bad Hair Day

Dendreon: A New Form of Shareholder Activism (DNDN)

Dendreon’s New Hurdle: The SEC (DNDN)

Dendreon Options Trading: Hope or Hearsay?

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%